Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Experimental Hematology ; (6): 1811-1815, 2018.
Artículo en Chino | WPRIM | ID: wpr-774381

RESUMEN

OBJECTIVE@#To investigate the charactcristics of CD180 expression and differentiation diagnostic value in B cell chronic lymphoproliferative disorders (B-CLPD) through detecting the mean fluorescence intensity(MFI)of CD180 in different sub types of B-CLPD,using multiparameter flow cytometry (FCM).@*METHODS@#The CD180 MFI of malignant B cells in 178 patients with B-CLPD was detected by FCM. The level of CD180 MFI in various types of B-CLPD was compared to the normal control group. The level of CD180 MFI among sub-types of B-CLPD was also compared.@*RESULTS@#(1) The expression levels of CD180 in B-CLPD was significantly lower as compared with the normal controls,except the spleen difuse red pulp lymphoma (SDRPL); (2) The CD180 MFI in chronic lymphocytic leukemia sCLL) was significantly lower as compared with other B-CLPD cells; (3) CD180 ware significantly overexpressed in HCL compared with MCL,LPL,and MZL (P <0.05); (4) In the spleen-derived B-CLPD,such as SMZL,HCL, HCL variation and SDRPL,the expression of CD180 has significant difference between lymphomas with or without villous.@*CONCLUSION@#Utilizing the multiparameter flow cytometry for defecting expression of CD180 and other immunological markers can more efficiently distinguish the subtypes of B-CLPD.


Asunto(s)
Humanos , Antígenos CD , Linfocitos B , Biomarcadores , Citometría de Flujo , Inmunofenotipificación , Leucemia Linfocítica Crónica de Células B , Trastornos Linfoproliferativos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA